Cleveland State University

Technology Transfer Office

Available Technologies - Abstract


Human leucine-rich A-2-glycoprotein-1 and aminopeptidase N as risk indicators for cancer.

Short Description A diagnostic test which may be used to determine whether an individual or test subject is at risk of developing or having cancer.
Abstract The present diagnostic tests, which involves assessing levels of LRG1, CD13, or the combination thereof in a urine or serum sample from a test subject, may provide additive predictive value beyond that seen with clinical and diagnostic risk factors currently employed by physicians.
Inventor(s) Dr. Aimin Zhou, Ph.D. Professor, Department of Chemistry.
Commercial Applications
  • Cancer treatment.
  • Non-invasive
  • Not site specific
  • Inexpensive
IP Information Pending U.S. Application
Related IP

Status Available
engaged learning
  • Partners
Campus Location
Parker Hannifin Hall, 214
2258 Euclid Avenue
Cleveland, OH 44115
Phone: 216.687.5108
This site contains files that require the free Adobe Reader to view.